Tocqueville Asset Management L.P. Compugen LTD Transaction History

Tocqueville Asset Management L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$1.75 - $2.95 $52,500 - $88,500	-30,000 Reduced 55.05%	24,500 $63,000
Q4 2023 Feb 12, 2024	SELL	$0.53 - $2.0 $11,660 - $44,000	-22,000 Reduced 28.76%	54,500 $107,000
Q3 2023 Nov 09, 2023	BUY	$0.88 - $1.31 $67,320 - $100,215	76,500 New	76,500 $71,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.